Karges Group
banner
kargesgroup.bsky.social
Karges Group
@kargesgroup.bsky.social
Full Professor in Biophysics at Faculty of Medicine, Ruhr University Bochum, Group Website: https://www.kargesgroup.ruhr-uni-bochum.de/
🚨 PhD Position in Medicinal Chemistry | Cancer Research
Join our Group for a fully funded PhD focused on developing novel anticancer therapies at the interface of chemistry, biology & medicine 🧪🧬 See further details at the link: jobs.ruhr-uni-bochum.de/jobposting/2...
Researcher/PhD (m/f/x) for Medicinal Biophysics
jobs.ruhr-uni-bochum.de
April 28, 2026 at 8:08 AM
Reposted by Karges Group
Manche #Tumoren wachsen so schnell, dass das Gefäßwachstum nicht mithält und sich im Inneren sauerstoffarme Bereiche bilden. Forscher der @kargesgroup.bsky.social an der @ruhr-uni-bochum.de haben einen Wirkstoff entwickelt, der ihre Behandlung mit photodynamischer Therapie möglich machen soll.
Photodynamische Therapie eröffnet neue Behandlungsoptionen bei schnell wachsenden Tumoren
Die photodynamische Therapie gegen Krebs basiert darauf, Patienten eine zunächst inaktive Substanz zu verabreichen, die erst im Tumor durch gezielte Lichtbestrahlung aktiviert wird.
healthcare-in-europe.com
April 10, 2026 at 11:11 AM
Excited to share that I got promoted to W3 Full Professor / Chair of Biophysics at the Faculty of Medicine at the Ruhr University Bochum. The group is now moving across campus into the newly built Center of Protein Diagnostics. news.rub.de/leute/2026-0...
April 8, 2026 at 6:40 AM
Reposted by Karges Group
Sauerstoffarme Bereiche von Tumoren überstehen oft die gängige Therapie. Ein neuer Wirkmechanismus ändert das.
Tumore unabhängig von Sauerstoff behandeln
Die meisten Tumore wachsen so schnell, dass das Gefäßwachstum nicht mithält und sich im Inneren sauerstoffarme Bereiche bilden. Ein neuer Wirkstoff könnte ihre Behandlung mit photodynamischer Therapie...
news.rub.de
April 7, 2026 at 9:22 AM
Milestone of the lab was just published in @jacs.acspublications.org about Metal-to-Metal Electron Transfer in a Ruthenium Deferasirox Conjugate for Hydroxyl Radical Mediated Hypoxic Photodynamic Therapy. Congrats to @nmontesdeocas.bsky.social and Zisis ! pubs.acs.org/doi/10.1021/...
April 7, 2026 at 6:54 AM
Check out our radio interview at @deutschlandfunk.de.web.brid.gy about the light induced induction of cuproptosis in drug resistant cancer cells (in German) @ruhr-uni-bochum.de
www.deutschlandfunk.de/cuproptose-m...
Cuproptose: Mit Kupfer gegen Krebs
www.deutschlandfunk.de
April 2, 2026 at 7:07 AM
I am delighted to congratulate my PhD student Nicolas @nmontesdeocas.bsky.social on his outstanding PhD defense, awarded summa cum laude. A remarkable milestone reflecting years of dedication, creativity, and rigorous research. Wishing him all the best for the exciting journey ahead!
March 31, 2026 at 6:33 AM
Big thanks to the Ruhr University Bochum for highlighting our research findings!
March 26, 2026 at 5:56 PM
Check out our article in Adv. Funct. Mater. about the Light Activated Induction of Cuproptosis with Copper Containing Polymeric Bodipy Nanoparticles. Congrats to Ricarda and @nmontesdeocas.bsky.social ! @ruhr-uni-bochum.de dx.doi.org/10.1002/adfm...
March 26, 2026 at 11:51 AM
Check out our Review Article in @chemicalscience.rsc.org about the classification of Metal Complexes in Medicine: Structural Scaffolds vs Functional Centers. Congrats to @nmontesdeocas.bsky.social ! @ruhr-uni-bochum.de dx.doi.org/10.1039/D6SC...
March 25, 2026 at 7:44 AM
We are very much looking forward to welcoming you in Bochum @ruhr-uni-bochum.de . Congrats for receiving the prestigious MSCA Fellowship! 🎉
Thrilled to share that I’ve been awarded a MSCA Postdoctoral Fellowship! 🎉
My project will be hosted by @kargesgroup.bsky.social at @ruhr-uni-bochum.de.

Excited to get started and very grateful for the support!
#MSCA #Postdoc #Research
February 13, 2026 at 7:42 AM
Reposted by Karges Group
Thrilled to share our latest collaboration with
@kargesgroup.bsky.social! Huge congrats to @antoniolinero.bsky.social & all co-authors, including
@nmontesdeocas.bsky.social. Exciting advances in photoactivated iridium nanomaterials & oncosis‑driven cancer cell death. doi.org/10.1021/acsa...
Encapsulation of a Cyclometalated Iridium(III) Photosensitizer into Nanosized Micelles for Oncosis-Inducing Photodynamic Therapy
The reliance of many anticancer agents on apoptosis often limits their therapeutic efficacy and contributes to the development of drug resistance. To overcome these challenges, alternative mechanisms ...
doi.org
February 6, 2026 at 7:54 AM
Check out our perspective in J. Med. Chem. @acsmedi.bsky.social about the Limitations of DCFH-DA for the Detection of ROS and Recommendations for Probe Selection. @ruhr-uni-bochum.de dx.doi.org/10.1021/acs....
Reactive Oxygen Species Detection with Fluorescent Probes: Limitations and Recommendations beyond DCFH-DA
Reactive oxygen species (ROS) are highly reactive molecules derived from molecular oxygen that play critical roles in cellular signaling, homeostasis, and the regulation of various physiological and pathological processes. Accurate detection and quantification of ROS are essential for elucidating their roles in health and disease. Despite significant advances in ROS probe development, challenges persist due to their short lifetimes, high reactivity, and their chemical diversity. This perspective article provides a critical evaluation of the limitations of the most commonly applied probe molecule DCFH-DA. Capitalizing on this, recommendations with practical applications in the lab for the specific detection of hydrogen peroxide, hydroxyl radical, singlet oxygen, superoxide anion, and peroxynitrite are provided. By integrating current knowledge on ROS probe technologies, this work aims to guide researchers in reliably assessing ROS in complex biological systems, thereby facilitating a deeper understanding of ROS-mediated processes and their implications for disease research and therapeutic development.
dx.doi.org
February 3, 2026 at 7:45 AM
Reposted by Karges Group
Happy to see this collaborative with Hui Chao and @kargesgroup.bsky.social out in @angewandtechemie.bsky.social. We designed Ir(III) complexes to trigger oncosis and activate the cyclic GMP–AMP synthase-stimulator of interferon genes pathway.
@chimieparistechpsl.bsky.social
doi.org/10.1002/anie...
December 9, 2025 at 2:16 AM
Incredibly proud to congratulate @antoniolinero.bsky.social on defending his PhD! He did a fantastic job. It’s been an honor to accompany him on this journey and to share this achievement with @joseruizlab.bsky.social, @vanesafm-isqch.bsky.social, @giampaolobarone.bsky.social and Dolores Santana. 🎉
After an outstanding PhD defence by @antoniolinero.bsky.social. we’re enjoying the best of Murcia with @joseruizlab.bsky.social , @giampaolobarone.bsky.social and @kargesgroup.bsky.social! Proud moment.
December 1, 2025 at 9:21 AM
🎥 Honored to be featured in a TV interview with WDR! We talked about our research and its impact — full interview (in German) here 👉 at 14:55 min: www.ardmediathek.de/video/lokalz...
October 24, 2025 at 7:07 AM
Proud to share our new @ChemRxiv preprint. We report on a novel Metal-to-Metal Electron Transfer Mechanism enabling Hydroxyl Radical Photoredox Catalysis in Hypoxic and Drug-Resistant Cancer Cells, addressing bottlenecks in photodynamic therapy. Please RT! chemrxiv.org/engage/chemr...
October 15, 2025 at 7:04 AM
Check out our paper in @chemcomm.rsc.org about the Red-Light Excitation of Ru(II)-Pt(II) Tetranuclear Complex for Combined Photoactivated Chemotherapy and Photodynamic Therapy. Congrats to Pia, Eleni, Julia, and @nmontesdeocas.bsky.social ! @ruhr-uni-bochum.de dx.doi.org/10.1039/D5CC...
October 8, 2025 at 7:04 AM
🚨 PhD Opportunity! 🚨
Join our group in Bioinorganic Chemistry to work on the synthesis & biological evaluation of metal complexes for anticancer therapy.
jobs.ruhr-uni-bochum.de/jobposting/8...
October 2, 2025 at 10:16 AM
Check out our paper in @inorgchemfront.rsc.org about the Induction of Oncosis by Light Activation with an Ir(III) complex conjugated to Albumin. Congrats to Antonio, Zisis, and Lisa. Fantastic collaboration with @joseruizlab.bsky.social ! @ruhr-uni-bochum.de @um.es dx.doi.org/10.1039/D5QI...
July 29, 2025 at 2:01 PM
Reposted by Karges Group
👉 Ein von der @kargesgroup.bsky.social an der @ruhr-uni-bochum.de entwickelter neuer Wirkstoffkomplex tötet Krebszellen auf eine so geschickte Art, dass sie im Sterben dem #Immunsystem den Weg zu #Metastasen zeigt, die sich an entfernten Orten im Körper entwickeln.
Sterbende Tumorzellen machen Metastasen zur Zielscheibe
Ein neuer Wirkstoff kann Krebszellen beseitigen und gleichzeitig das Immunsystem trainieren, solche Zellen überall im Körper zu vernichten.
healthcare-in-europe.com
July 29, 2025 at 6:33 AM
Check out our paper in J. Med. Chem. @acsbiol.bsky.social @acsmedi.bsky.social about the induction of immunogenic cell death by a gallium complex for chemoimmunotherapy. Congrats to Zisis and Yassin! @ruhr-uni-bochum.de
dx.doi.org/10.1021/acs....
July 18, 2025 at 6:09 AM
Honored to be giving the plenary lecture for the Inorganic Devision at the Brazilian Chemistry Conference #48RASBQ
June 11, 2025 at 1:02 PM
Wonderful presenting some of our research at Universidade Federal de Juiz de Fora @ufjfoficial.bsky.social Thanks to Luiz for the kind invitation! @ruhr-uni-bochum.de
June 6, 2025 at 5:01 PM
Check out our study in @acsmedi.bsky.social about the "Induction of Cuproptosis with a Highly Cytotoxic Tripodal Cu(II) Complex". Congrats to Ricarda and @nmontesdeocas.bsky.social @ruhr-uni-bochum.de
pubs.acs.org/doi/abs/10.1...
June 4, 2025 at 9:54 AM